Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frieder Kees

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Expert Opinion on Pharmacotherapy|May 24, 2013
Dimethyl fumarate : a Janus-faced substance?Frieder Kees
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2016
Unbound fraction of fluconazole and linezolid in human plasma as determined by ultrafiltration: Impact of membrane typeAlexander Kratzer, Frieder Kees, Christoph Dorn
The Journal of Antimicrobial Chemotherapy|July 21, 2006
In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in miceKristina Lotter, Klaus Höcherl, Michael Bucher, et al.
Critical Care Medicine|February 11, 2003
Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemiaMichael Bucher, Frieder Kees, Kai Taeger, et al.
Kidney International|May 20, 2004
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expressionKlaus Höcherl, Frieder Kees, Bernhard K Krämer, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2011
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patientsMartin G Kees, Susanne Weber, Frieder Kees, et al.
Kidney International|June 14, 2013
The cyclic GMP-dependent protein kinase Iα suppresses kidney fibrosisElisabeth Schinner, Andrea Schramm, Frieder Kees, et al.
Intensive Care Medicine|February 26, 2008
Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapyJulia Langgartner, Antje Vasold, Thomas Glück, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 30, 2017
Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combinationVeronika Wetzl, Elisabeth Schinner, Frieder Kees, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in ratsJens Koehler, Thomas Kuehnel, Frieder Kees, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Expert Opinion on Pharmacotherapy|May 24, 2013
Dimethyl fumarate : a Janus-faced substance?Frieder Kees
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2016
Unbound fraction of fluconazole and linezolid in human plasma as determined by ultrafiltration: Impact of membrane typeAlexander Kratzer, Frieder Kees, Christoph Dorn
The Journal of Antimicrobial Chemotherapy|July 21, 2006
In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in miceKristina Lotter, Klaus Höcherl, Michael Bucher, et al.
Critical Care Medicine|February 11, 2003
Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemiaMichael Bucher, Frieder Kees, Kai Taeger, et al.
Kidney International|May 20, 2004
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expressionKlaus Höcherl, Frieder Kees, Bernhard K Krämer, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2011
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patientsMartin G Kees, Susanne Weber, Frieder Kees, et al.
Kidney International|June 14, 2013
The cyclic GMP-dependent protein kinase Iα suppresses kidney fibrosisElisabeth Schinner, Andrea Schramm, Frieder Kees, et al.
Intensive Care Medicine|February 26, 2008
Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapyJulia Langgartner, Antje Vasold, Thomas Glück, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 30, 2017
Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combinationVeronika Wetzl, Elisabeth Schinner, Frieder Kees, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in ratsJens Koehler, Thomas Kuehnel, Frieder Kees, et al.
Pageof 6